Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response evaluation of Foster (beclometasone + formoterol) in mild asthma using FEV1, AMP challenge, and FeNO
2007-004345-14Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of beclometasone dipropionate + formoterol, formoterol and beclomethasone dipropionate in asthma, sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: AUC(0–4h) FEV1 on Day 1 of each 3-day study period. Started Oct 2007; status: completed.
02
Drugs
beclometasone dipropionate + formoterolformoterolbeclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-004345-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004345-14.